Posted On: 12/08/2014 10:35:31 PM
Post# of 94315
$PFE Headlines
Visa, Goldman Sachs powering Dow to 18,000
4:29 p.m. Dec. 5, 2014
- Tomi Kilgore
Will Santa come to Broad and Wall?
1:54 p.m. Dec. 1, 2014
- The Trading Deck
Dow buy signals push index higher
11:39 a.m. Nov. 24, 2014
- The Trading Deck
Are consumers getting gouged on health care?
9:35 a.m. Nov. 22, 2014
- Russ Britt
AstraZeneca advances in London; pound rises as inflation ticks up
11:59 a.m. Nov. 18, 2014
- Carla Mozee
Zoetis unveils $500 million buyback plan
7:52 a.m. Nov. 18, 2014
- Michael Calia
AstraZeneca forecasts revenue of $45 bln by 2023
2:42 a.m. Nov. 18, 2014
- MarketWatch.com
Updates, advisories and surprises
6:01 p.m. Nov. 17, 2014
- MarketWatch
Urban Outfitters slides after earnings miss expectations
4:43 p.m. Nov. 17, 2014
- Sue Chang
U.K. stocks rise on Draghi stimulus talk; AstraZeneca drops
12:04 p.m. Nov. 17, 2014
- Carla Mozee
Pfizer, Germany’s Merck strike deal to develop cancer tumor treatment
11:05 a.m. Nov. 17, 2014
- Natalia Drozdiak
Pfizer, Germany's Merck to develop tumor treatment
10:22 a.m. Nov. 17, 2014
- MarketWatch.com
Halliburton-Baker Hughes Deal: Antitrust Issues?
9:27 a.m. Nov. 17, 2014
- MarketWatch
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop
9:24 a.m. Nov. 17, 2014
- MarketWatch
Ford may be a buy, but U.S. stocks look stretched vs. the rest of the world
9:11 a.m. Nov. 17, 2014
- Shawn Langlois
Pfizer's stock drops after profit outlook cut
8:04 a.m. Nov. 17, 2014
- Tomi Kilgore
Pfizer's stock falls 1.6% in premarket trade
7:49 a.m. Nov. 17, 2014
- Tomi Kilgore
Pfizer previous EPS guidance was $1.50-$1.59
3:22 a.m. Nov. 17, 2014
- Karen Friar
Pfizer cuts 2014 EPS guidance to $1.40 to $1.49
3:22 a.m. Nov. 17, 2014
- Karen Friar
Pfizer, Merck to jointly develop cancer treatment
3:20 a.m. Nov. 17, 2014
- Karen Friar
Generic EpiPen Could Give These 2 Stocks A Jolt Of Adrenaline
4:48 p.m. Today4:48 p.m. Dec. 8, 2014
- Seeking Alpha
Assessing The Magnitude Of Pfizer's Coming Dividend Increase
3:11 p.m. Today3:11 p.m. Dec. 8, 2014
- Seeking Alpha
Merck Acquiring Cubist, Focusing On Hospital Care
10:48 a.m. Today10:48 a.m. Dec. 8, 2014
- Investors Business Daily
Pfizer Reports Expansion of Rare Disease Research with Establishment of Gene Therapy Platform
7:07 a.m. Today7:07 a.m. Dec. 8, 2014
- benzinga.com
Perky Dow Dividend Dogs Pop Up In December
4:14 a.m. Today4:14 a.m. Dec. 8, 2014
- Seeking Alpha
Health and Tech Funds Step Up
11:06 p.m. Dec. 7, 2014
- The Wall Street Journal Interactive Edition
What Eli Lilly Can Do To Keep Its Amazing Rally Going In 2015
5:07 p.m. Dec. 5, 2014
- Seeking Alpha
Will Someone Take GlaxoSmithKline Out Of Its Misery?
4:11 p.m. Dec. 5, 2014
- Seeking Alpha
The 4 Stocks That Carried the Market on Friday
3:30 p.m. Dec. 5, 2014
- 247WallSt.com
Bayer Doesn’t Look Ready for Animal Magnetism
8:22 a.m. Dec. 5, 2014
- The Wall Street Journal Interactive Edition
Can Albert Einstein's Math Get You To The Finish Line? Retirement Portfolio Quarterly Review
3:57 p.m. Dec. 4, 2014
- Seeking Alpha
Hot Drugmakers Build More Labs, Grab Space In Boston
3:47 p.m. Dec. 4, 2014
- Investors Business Daily
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
11:29 a.m. Dec. 4, 2014
- CNW Group
Dividend Dogs Of Healthcare: A 29.17% Advantage For The 5 Lowest Price High Yield Stocks
9:37 a.m. Dec. 4, 2014
- Seeking Alpha
5 Prime Dividend Dogs Of Healthcare Hound 11% To 45.4% November Upsides
3:40 a.m. Dec. 4, 2014
- Seeking Alpha
Puma Biotechnology Down on Delay in Neratinib NDA Filing - Analyst Blog
5:10 p.m. Dec. 3, 2014
- Zacks.com
Puma Biotech Stock Plunges On Drug Filing Delay
10:43 a.m. Dec. 3, 2014
- Investors Business Daily
Zoetis in a Growing Global Animal Health Industry
10:32 a.m. Dec. 3, 2014
- GuruFocus.com
2014’s Underperforming Large-Cap Stocks That Could Be 2015 Winners
7:37 a.m. Dec. 3, 2014
- 247WallSt.com
Pete Najarian Sees Unusual Options Activity In Pfizer
6:35 a.m. Dec. 3, 2014
- benzinga.com
Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.
8:06 a.m. Today8:06 a.m. Dec. 8, 2014
- PR Newswire - PRF
Pfizer Expands Rare Disease Research with Establishment of Gene
Therapy Platform
8:02 a.m. Today8:02 a.m. Dec. 8, 2014
- BusinessWire - BZX
iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for Discovery and Development of Cancer Immunosuppression Targets
2:30 a.m. Today2:30 a.m. Dec. 8, 2014
- PR Newswire - PRF
Tenet Healthcare Names Dr. Freda C. Lewis-Hall to Board of Directors
4:00 p.m. Dec. 4, 2014
- BusinessWire - BZX
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
11:29 a.m. Dec. 4, 2014
- PR Newswire - PRF
Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
10:00 a.m. Dec. 4, 2014
- PR Newswire - PRF
Phase 3 Results Published in TheNew England Journal of
Medicine Show Superiority of Pfizer’s XALKORI® (crizotinib)
Compared to Platinum-Based Chemotherapy in Previously Untreated Patients
With ALK-Positive Advanced Non-Small Cell Lung Cancer
5:07 p.m. Dec. 3, 2014
- BusinessWire - BZX
Diplomat selected as a limited-distribution pharmacy partner by Pfizer; Diplomat to dispense Xalkori®, Bosulif®, Sutent® and Inlyta®
4:37 p.m. Dec. 3, 2014
- PR Newswire - PRF
Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration
4:05 p.m. Dec. 2, 2014
- PR Newswire - PRF
BioClinica Names Dr. John Hubbard Chief Executive Officer
9:14 a.m. Dec. 1, 2014
- PR Newswire - PRF
Pfizer Completes Acquisition of Baxter’s Marketed Vaccines
7:30 a.m. Dec. 1, 2014
- BusinessWire - BZX
TechNavio Names Pfizer, Merck, F. Hoffmann-La Roche as Top Companies in
the Global Human Growth Hormone Market
1:15 p.m. Nov. 20, 2014
- BusinessWire - BZX
Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research
9:00 a.m. Nov. 18, 2014
- PR Newswire - PRF
TRUMENBA® (Meningococcal Group B Vaccine) is
Now Available
8:30 a.m. Nov. 18, 2014
- BusinessWire - BZX
Novel Agreement Expands Access to Pfizer’s Contraceptive, Sayana®
Press, for Women Most in Need in the World’s Poorest Countries
11:00 a.m. Nov. 13, 2014
- BusinessWire - BZX
Pfizer Highlights Leadership in Rheumatology and Inflammation with
Data to be Presented at the ACR/ARHP 2014 Annual Meeting
8:01 a.m. Nov. 12, 2014
- BusinessWire - BZX
Insider Trading Recap for AK Steel, Pfizer, Chesapeake Energy, Plug Power, Twitter, and RF Micro Devices
8:45 a.m. Nov. 11, 2014
- PR Newswire - PRF
Amy Schulman Joins The Board Of Directors Of Blue Buffalo
9:34 a.m. Nov. 10, 2014
- PR Newswire - PRF
Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At
Healthcare Conference
11:00 a.m. Nov. 5, 2014
- BusinessWire - BZX
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix
8:55 a.m. Nov. 4, 2014
- PR Newswire - PRF
Visa, Goldman Sachs powering Dow to 18,000
4:29 p.m. Dec. 5, 2014
- Tomi Kilgore
Will Santa come to Broad and Wall?
1:54 p.m. Dec. 1, 2014
- The Trading Deck
Dow buy signals push index higher
11:39 a.m. Nov. 24, 2014
- The Trading Deck
Are consumers getting gouged on health care?
9:35 a.m. Nov. 22, 2014
- Russ Britt
AstraZeneca advances in London; pound rises as inflation ticks up
11:59 a.m. Nov. 18, 2014
- Carla Mozee
Zoetis unveils $500 million buyback plan
7:52 a.m. Nov. 18, 2014
- Michael Calia
AstraZeneca forecasts revenue of $45 bln by 2023
2:42 a.m. Nov. 18, 2014
- MarketWatch.com
Updates, advisories and surprises
6:01 p.m. Nov. 17, 2014
- MarketWatch
Urban Outfitters slides after earnings miss expectations
4:43 p.m. Nov. 17, 2014
- Sue Chang
U.K. stocks rise on Draghi stimulus talk; AstraZeneca drops
12:04 p.m. Nov. 17, 2014
- Carla Mozee
Pfizer, Germany’s Merck strike deal to develop cancer tumor treatment
11:05 a.m. Nov. 17, 2014
- Natalia Drozdiak
Pfizer, Germany's Merck to develop tumor treatment
10:22 a.m. Nov. 17, 2014
- MarketWatch.com
Halliburton-Baker Hughes Deal: Antitrust Issues?
9:27 a.m. Nov. 17, 2014
- MarketWatch
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop
9:24 a.m. Nov. 17, 2014
- MarketWatch
Ford may be a buy, but U.S. stocks look stretched vs. the rest of the world
9:11 a.m. Nov. 17, 2014
- Shawn Langlois
Pfizer's stock drops after profit outlook cut
8:04 a.m. Nov. 17, 2014
- Tomi Kilgore
Pfizer's stock falls 1.6% in premarket trade
7:49 a.m. Nov. 17, 2014
- Tomi Kilgore
Pfizer previous EPS guidance was $1.50-$1.59
3:22 a.m. Nov. 17, 2014
- Karen Friar
Pfizer cuts 2014 EPS guidance to $1.40 to $1.49
3:22 a.m. Nov. 17, 2014
- Karen Friar
Pfizer, Merck to jointly develop cancer treatment
3:20 a.m. Nov. 17, 2014
- Karen Friar
Generic EpiPen Could Give These 2 Stocks A Jolt Of Adrenaline
4:48 p.m. Today4:48 p.m. Dec. 8, 2014
- Seeking Alpha
Assessing The Magnitude Of Pfizer's Coming Dividend Increase
3:11 p.m. Today3:11 p.m. Dec. 8, 2014
- Seeking Alpha
Merck Acquiring Cubist, Focusing On Hospital Care
10:48 a.m. Today10:48 a.m. Dec. 8, 2014
- Investors Business Daily
Pfizer Reports Expansion of Rare Disease Research with Establishment of Gene Therapy Platform
7:07 a.m. Today7:07 a.m. Dec. 8, 2014
- benzinga.com
Perky Dow Dividend Dogs Pop Up In December
4:14 a.m. Today4:14 a.m. Dec. 8, 2014
- Seeking Alpha
Health and Tech Funds Step Up
11:06 p.m. Dec. 7, 2014
- The Wall Street Journal Interactive Edition
What Eli Lilly Can Do To Keep Its Amazing Rally Going In 2015
5:07 p.m. Dec. 5, 2014
- Seeking Alpha
Will Someone Take GlaxoSmithKline Out Of Its Misery?
4:11 p.m. Dec. 5, 2014
- Seeking Alpha
The 4 Stocks That Carried the Market on Friday
3:30 p.m. Dec. 5, 2014
- 247WallSt.com
Bayer Doesn’t Look Ready for Animal Magnetism
8:22 a.m. Dec. 5, 2014
- The Wall Street Journal Interactive Edition
Can Albert Einstein's Math Get You To The Finish Line? Retirement Portfolio Quarterly Review
3:57 p.m. Dec. 4, 2014
- Seeking Alpha
Hot Drugmakers Build More Labs, Grab Space In Boston
3:47 p.m. Dec. 4, 2014
- Investors Business Daily
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
11:29 a.m. Dec. 4, 2014
- CNW Group
Dividend Dogs Of Healthcare: A 29.17% Advantage For The 5 Lowest Price High Yield Stocks
9:37 a.m. Dec. 4, 2014
- Seeking Alpha
5 Prime Dividend Dogs Of Healthcare Hound 11% To 45.4% November Upsides
3:40 a.m. Dec. 4, 2014
- Seeking Alpha
Puma Biotechnology Down on Delay in Neratinib NDA Filing - Analyst Blog
5:10 p.m. Dec. 3, 2014
- Zacks.com
Puma Biotech Stock Plunges On Drug Filing Delay
10:43 a.m. Dec. 3, 2014
- Investors Business Daily
Zoetis in a Growing Global Animal Health Industry
10:32 a.m. Dec. 3, 2014
- GuruFocus.com
2014’s Underperforming Large-Cap Stocks That Could Be 2015 Winners
7:37 a.m. Dec. 3, 2014
- 247WallSt.com
Pete Najarian Sees Unusual Options Activity In Pfizer
6:35 a.m. Dec. 3, 2014
- benzinga.com
Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.
8:06 a.m. Today8:06 a.m. Dec. 8, 2014
- PR Newswire - PRF
Pfizer Expands Rare Disease Research with Establishment of Gene
Therapy Platform
8:02 a.m. Today8:02 a.m. Dec. 8, 2014
- BusinessWire - BZX
iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for Discovery and Development of Cancer Immunosuppression Targets
2:30 a.m. Today2:30 a.m. Dec. 8, 2014
- PR Newswire - PRF
Tenet Healthcare Names Dr. Freda C. Lewis-Hall to Board of Directors
4:00 p.m. Dec. 4, 2014
- BusinessWire - BZX
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
11:29 a.m. Dec. 4, 2014
- PR Newswire - PRF
Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
10:00 a.m. Dec. 4, 2014
- PR Newswire - PRF
Phase 3 Results Published in TheNew England Journal of
Medicine Show Superiority of Pfizer’s XALKORI® (crizotinib)
Compared to Platinum-Based Chemotherapy in Previously Untreated Patients
With ALK-Positive Advanced Non-Small Cell Lung Cancer
5:07 p.m. Dec. 3, 2014
- BusinessWire - BZX
Diplomat selected as a limited-distribution pharmacy partner by Pfizer; Diplomat to dispense Xalkori®, Bosulif®, Sutent® and Inlyta®
4:37 p.m. Dec. 3, 2014
- PR Newswire - PRF
Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration
4:05 p.m. Dec. 2, 2014
- PR Newswire - PRF
BioClinica Names Dr. John Hubbard Chief Executive Officer
9:14 a.m. Dec. 1, 2014
- PR Newswire - PRF
Pfizer Completes Acquisition of Baxter’s Marketed Vaccines
7:30 a.m. Dec. 1, 2014
- BusinessWire - BZX
TechNavio Names Pfizer, Merck, F. Hoffmann-La Roche as Top Companies in
the Global Human Growth Hormone Market
1:15 p.m. Nov. 20, 2014
- BusinessWire - BZX
Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research
9:00 a.m. Nov. 18, 2014
- PR Newswire - PRF
TRUMENBA® (Meningococcal Group B Vaccine) is
Now Available
8:30 a.m. Nov. 18, 2014
- BusinessWire - BZX
Novel Agreement Expands Access to Pfizer’s Contraceptive, Sayana®
Press, for Women Most in Need in the World’s Poorest Countries
11:00 a.m. Nov. 13, 2014
- BusinessWire - BZX
Pfizer Highlights Leadership in Rheumatology and Inflammation with
Data to be Presented at the ACR/ARHP 2014 Annual Meeting
8:01 a.m. Nov. 12, 2014
- BusinessWire - BZX
Insider Trading Recap for AK Steel, Pfizer, Chesapeake Energy, Plug Power, Twitter, and RF Micro Devices
8:45 a.m. Nov. 11, 2014
- PR Newswire - PRF
Amy Schulman Joins The Board Of Directors Of Blue Buffalo
9:34 a.m. Nov. 10, 2014
- PR Newswire - PRF
Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At
Healthcare Conference
11:00 a.m. Nov. 5, 2014
- BusinessWire - BZX
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix
8:55 a.m. Nov. 4, 2014
- PR Newswire - PRF
(0)
(0)
